About Pertuzumab,Trastuzumab,Hyaluronidase
            
            Class: | Monoclonal antibody combination (Pertuzumab and Trastuzumab) with Hyaluronidase as a delivery enhancer  
Use: | Treatment of HER2-positive breast cancer in combination with chemotherapy for early and metastatic breast cancer  
Adult dose: | 600 mg Pertuzumab and 600 mg Trastuzumab administered subcutaneously every 3 weeks; 20,000 Units of Hyaluronidase for delivery  
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended  
Side effects: | Common sid
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody combination (Pertuzumab and Trastuzumab) with Hyaluronidase as a delivery enhancer
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of HER2-positive breast cancer in combination with chemotherapy for early and metastatic breast cancer
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: F. Hoffmann-La Roche Ltd., SWITZERLAND
                    
                    
                    Package Size
                    1 Glass Vial (10 ml)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 24772.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        600 mg Pertuzumab and 600 mg Trastuzumab administered subcutaneously every 3 weeks; 20,000 Units of Hyaluronidase for delivery
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include diarrhea, nausea, fatigue, rash, and infusion-related reactions; potential for cardiac dysfunction
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to Pertuzumab, Trastuzumab, or Hyaluronidase; pregnancy (category D)
         
        
        
            
                Important Warnings
            
            Monitor for signs of cardiac dysfunction; infusion reactions may occur; fetal harm if administered during pregnancy; use caution in patients with a history of heart disease
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.